- Nachrichtendetail
-
27.06.2024 14:15:19 - dpa-AFX: *LIGAND PARTNER VERONA PHARMA ANNOUNCES FDA APPROVAL OF OHTUVAYRE FOR MAINTENANCE TREATMENT OF COPD
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 102,210 | 16.08.24 22:14:23 | -0,920 | -0,89% | 102,200 | 106,400 | 103,270 | 102,210 |
